What is the price target for UHS stock?
26 analysts have analysed UHS and the average price target is 253.23 USD. This implies a price increase of 41.83% is expected in the next year compared to the current price of 178.55.
NYSE:UHS • US9139031002
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for UNIVERSAL HEALTH SERVICES-B (UHS).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-02 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-27 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2026-02-26 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-22 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-07 | TD Cowen | Maintains | Buy -> Buy |
| 2026-01-07 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-12-02 | Guggenheim | Maintains | Buy -> Buy |
| 2025-11-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-30 | RBC Capital | Maintains | Sector Perform -> Sector Performer |
| 2025-10-29 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2025-10-29 | Guggenheim | Maintains | Buy -> Buy |
| 2025-10-29 | UBS | Maintains | Buy -> Buy |
| 2025-10-28 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-07 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2025-10-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-09-18 | Barclays | Maintains | Overweight -> Overweight |
| 2025-08-26 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2025-08-19 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-08-14 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-14 | Baird | Maintains | Neutral -> Neutral |
| 2025-08-04 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-07-30 | Barclays | Maintains | Overweight -> Overweight |
| 2025-07-16 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2025-04-30 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-04-29 | Barclays | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 14.282B 6.59% | 15.828B 10.82% | 17.365B 9.71% | 18.696B 7.67% | 19.629B 4.99% | 20.686B 5.38% | 20.75B 0.31% | |
| EBITDA YoY % growth | 1.743B 9.97% | 2.267B 30.01% | 2.613B 15.27% | 2.704B 3.49% | 2.821B 4.33% | 2.902B 2.87% | N/A | |
| EBIT YoY % growth | 1.175B 17.12% | 1.682B 43.09% | 1.994B 18.56% | 2.074B 4.01% | 2.157B 4.00% | 2.233B 3.52% | N/A | |
| Operating Margin | 8.23% | 10.63% | 11.48% | 11.09% | 10.99% | 10.79% | N/A | |
| EPS YoY % growth | 10.55 6.46% | 16.64 57.73% | 21.76 30.77% | 23.71 8.94% | 25.83 8.96% | 28.35 9.74% | 29.06 2.51% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 5.49 13.49% | 5.92 10.72% | 5.94 4.35% | 6.36 8.19% | 6.19 12.62% | 6.55 10.65% | 6.42 8.12% | 7.03 10.43% | 6.95 12.34% | 7.28 11.05% | 6.71 4.48% | 7.55 7.45% |
| Revenue Q2Q % growth | 4.435B 8.18% | 4.618B 7.80% | 4.794B 6.65% | 4.832B 7.71% | 4.683B 5.59% | 4.857B 5.18% | 5.02B 4.71% | 5.056B 4.64% | 4.989B 6.53% | 5.086B 4.71% | 5.224B 4.06% | 5.33B 5.42% |
| EBITDA Q2Q % growth | 643M 6.60% | 683.58M -14.62% | 683.57M -30.04% | 725.62M -36.12% | 683.37M 6.28% | 715.31M 4.64% | 715.41M 4.66% | 755.43M 4.11% | 736.69M 7.80% | 760.75M 6.35% | 726.26M 1.52% | 816.62M 8.10% |
| EBIT Q2Q % growth | 478.63M 5.23% | 516.94M 3.33% | 518.06M -0.70% | 548.56M 6.06% | 507.02M 5.93% | 535.71M 3.63% | 542M 4.62% | 568.01M 3.55% | 525.57M 3.66% | 543.65M 1.48% | 557.75M 2.91% | 599.4M 5.53% |
All data in USD
26 analysts have analysed UHS and the average price target is 253.23 USD. This implies a price increase of 41.83% is expected in the next year compared to the current price of 178.55.
UNIVERSAL HEALTH SERVICES-B (UHS) will report earnings on 2026-04-27, after the market close.
The consensus EPS estimate for the next earnings of UNIVERSAL HEALTH SERVICES-B (UHS) is 5.49 USD and the consensus revenue estimate is 4.43B USD.
The number of analysts covering UNIVERSAL HEALTH SERVICES-B (UHS) is 26.